Search results
Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study
US News & World Report· 6 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that the immunotherapy ...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 7 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell ...
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 2 days agoCARsgen chief medical officer Raffaele Baffa said: “The preliminary results of the ongoing study...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
LiveScience· 5 days agoFor many people, the treatment has been life-changing — however, as the first CAR T-cell therapy was...
Case study reveals important new details about rare second cancers related to CAR-T therapy
Medical Xpress· 6 days agoA new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important ...
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst - Legend...
Benzinga· 2 days agoShares of cell therapy company Legend Biotech Corp LEGN were trading lower on Monday, after being...